OurView Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: low-cost compounded GLP-1 via a membership savings model
Price is where OurView Health scores best in our breakdown.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications. Weight loss is compounded semaglutide (from $75) and tirzepatide (from $135), shipped in 30-day supplies; it also covers TRT/HRT, women's BHRT, and wellness peptides. Medications are compounded by an unnamed licensed third-party pharmacy. A full legal suite is published; the site claims LegitScript Approval, not independently verified here.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to OurView Health
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Brightmeds
Best for: compounded or brand GLP-1 bundled with TRT and peptides for men
Editorial score · methodology
OurView Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $75/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored OurView Health
Each dimension is scored algorithmically from OurView Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.8/10At $75/mo, OurView Health runs about 56% below the $169 median for GLP-1 providers.
Effectiveness25%
7.8/10OurView Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-02).
Accessibility10%
5.8/10OurView Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.6/10OurView Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this OurView Health review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with OurView Health
We walked OurView Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a quick 3-minute questionnaire (no payment required).
- 2Become a member to unlock pharmacy-direct pricing.
- 3Meet with a US-licensed provider who reviews intake and builds a treatment plan.
- 4Purchase the prescribed medication, which ships to your door.
- Starting monthly prices shown up front: Semaglutide from $75/month, Tirzepatide from $135/month, varying by weekly dose.
- Prices are framed as member 'pharmacy-direct pricing' unlocked after joining.
- Initial questionnaire requires no payment.
- Describes 24/7 support and 1:1 physician guidance; fully online.
OurView Health customer support
- Phone
- (573) 687-8439
- Hours
- 24/7 support
GLP-1 medications OurView Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides OurView Health offers
Beyond GLP-1s, OurView Health also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check OurView Health's current pricing and active discounts before you decide.
What we like
- Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
- Clear product pricing with no contracts; medication shipped to your door (30-day supply)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
- Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)
Watch-outs
- 'Starting at' prices likely require Savings Club membership and/or a longer plan
- Compounding pharmacy partner not named ('licensed third-party pharmacy')
- 'LegitScript Approved' is stated on the site but was not independently verified here
- Operating medical entity not clearly named (site operated by a marketing agency)
Is OurView Health worth it? Our verdict
OurView Health positions itself around one thing: low-cost compounded GLP-1 via a membership savings model. It runs $75/month — toward the affordable end of the market.
Beyond the core GLP-1 program, OurView Health leans on Savings Club membership, TRT & HRT, and Peptides & wellness.
How much OurView Health actually costs
- Compounded semaglutide — $75/month
- Compounded tirzepatide — $135/month
That puts OurView Health below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, Sesame Care runs semaglutide and tirzepatide from $59/month — worth pricing against OurView Health before you commit.
Medications: what OurView Health prescribes
OurView Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who OurView Health is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
OurView Health earns its place on the shortlist mainly on price: at $75/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where OurView Health scores best in our breakdown.
Ready to start with OurView Health?
Starting at $75/month. See current pricing and start your free consultation.
OurView Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Oak.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this OurView Health review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See OurView Health's current pricing
Plans start at $75/month. Start your free consultation to check eligibility and today's price.